Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Lung Neoplasms 3 Prostatic Neoplasms 2 Melanoma 2 Glioma 2 Thyroid Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Skin Neoplasms 1 Recurrence 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Lymphoma, Follicular 1 Locally Advanced Pancreatic Cancer 1 Liver Cirrhosis 1 Inflammatory Bowel Diseases 1 Hypertension, Portal 1 Gynecologic Cancer 1 Fibrosis 1 Dysplastic Nevus Syndrome 1 Disease 1 Depressive Disorder, Major 1 Cysts 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Diagnostic Imaging × Clear all

NCT06381531 2025-04-11

TRACE

Tata Memorial Centre

10,000 enrolled

Brain Neoplasms, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡